A Comparative Study of Nipple Sensation Preservation After Nipple-Sparing Mastectomy With Conventional, Endoscopic, Robotic Techniques

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorCandiolo Cancer Institute - IRCCS

About this trial

The goal of this comparative study is to learn how different surgical methods affect nipple and skin sensation after nipple-sparing mastectomy (NSM). The study will compare three types of NSM: conventional, endoscopic, and robotic.

The main question it aims to answer is:

How much nipple sensation do participants keep after each type of surgery?

Researchers will also look at surgery-related complications, patient-reported outcomes like body image and quality of life, and tissue analysis to see if there is a link between nerve structures and sensation.

Participants will:

Have NSM using one of the three surgical approaches

Receive breast reconstruction with an implant during the same surgery

Complete nipple sensation tests before and at 1, 3, and 6 months after surgery

Answer surveys about their quality of life and body image

Provide surgical tissue for analysis (as part of the planned procedure)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female patients aged ≥18 years.

Diagnosed with early-stage breast cancer or deemed at high risk for breast cancer (eg. BRCA1-2 mutations).

Candidates for Nipple-Sparing Mastectomy (NSM).

Able to provide informed consent.

Disqualifiers

Previous breast surgery.

History of radiation therapy to the chest/breast area.

Active or non-controlled diabetes mellitus.

Neuropathies causing potentially altered skin sensation.

Trial population

The study population will consist of female patients aged 18 years or older, eligible for mastectomy for early-stage breast cancer or high-risk conditions, who meet the study eligibility criteria. A total of 90 patients will be recruited at Candiolo Cancer Institute in Torino (Italy).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Nipple Sensation Assessment

    Diagnostic test

    the measurement of nipple sensation preservation, will be conducted using the Semmes-Weinstein esthesiometer. The clinician will use the device to touch the nipple and the surrounding quadrants of the skin, applying filaments of increasing calibers (0.07gr, 0.4gr, 2.0gr, 4.0gr, 300gr), and the lightest caliber perceived by the patient will be recorded. This assessment will be conducted at four different times: * Before surgery, to assess baseline sensation. * 1 month after surgery. * 3 months after surgery. * 6 months after surgery.

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: Conventional Nipple-Sparing Mastectomy (C-NSM)1 intervention
Group B: Endoscopic Nipple-Sparing Mastectomy (E-NSM)1 intervention
Group C: Robotic Nipple-Sparing Mastectomy (R-NSM)1 intervention

Trial outcomes

Primary outcomes

1

measurement of nipple sensation preservation

The primary objective, the measurement of nipple sensation preservation, will be conducted using the Semmes-Weinstein esthesiometer. The clinician will use the device to touch the nipple and the surrounding quadrants of the skin, applying filaments of increasing calibers (0.07gr, 0.4gr, 2.0gr, 4.0gr, 300gr), and the lightest caliber perceived by the patient will be recorded.

Time frame
This assessment will be conducted at four different times: • Before surgery, to assess baseline sensation. • 1 month after surgery. • 3 months after surgery. • 6 months after surgery.

Secondary outcomes

1

surgical outcomes

nipple-areola complex necrosis, skin flaps necrosis, infection, bleeding, seroma, wound dehiscence,

Time frame
from enrollment to 3 months
2

anatomopathological findings

the presence or absence of sensory cutaneous receptors in the subcutaneous layer of the specimen and their possible correlation to the degree of cutaneous sensation

Time frame
30-60 days post-surgery
3

PROMs

Questionnaires will be administered to the patients to assess patient-reported outcomes: Hopwood Body Image Scale (score 0 to 30, higher scores meaning a worst outcome), and EORTC - European Organisation for Research and Treatment of Cancer, BR-23 questionnaire (no total score, each question compared individually between groups)

Time frame
From enrollment to 6 monts postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.